Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Astellas Pharma
Pharma
'March-in' drug pricing provisions advance in the US
While “march-in” rights have yet to materialize in the U.S., the controversial price-cutting measure seems to be gaining traction with the government.
Fraiser Kansteiner
Dec 7, 2023 11:58am
Padcev, Keytruda combo posts 'practice-changing' win
Sep 22, 2023 11:28am
FibroGen CEO Enrique Conterno hits the exit after 3-year stint
Jul 25, 2023 2:02pm
Daiichi scores FDA nod for leukemia med Vanflyta
Jul 21, 2023 10:05am
Astellas sells Netherlands manufacturing plant to CDMO Delpharm
May 26, 2023 9:25am
Astellas' menopause drug, after delay, crosses FDA finish line
May 12, 2023 4:52pm